Mosaic ImmunoEngineering EBITDA Growth & History (CPMV)

Mosaic ImmunoEngineering's calculated EBITDA was −$602,113 for fiscal 2025.

View full Mosaic ImmunoEngineering company overview

Mosaic ImmunoEngineering annual ebitda history

Mosaic ImmunoEngineering annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20252025-12-31−$602,113$235,537
20242024-12-31−$837,650$79,010
20232023-12-31−$916,660$1.3M
20222022-12-31−$2.2M

Mosaic ImmunoEngineering ebitda trends

Between the periods ended 2022-12-31 and 2025-12-31, Mosaic ImmunoEngineering's ebitda increased from −$2.2M to −$602,113, a change of $1.6M. The latest reported quarter, Q2 2026, shows −$156,721.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Mosaic ImmunoEngineering source filings ↗

Community posts

It’s quiet here.

No posts about CPMV yet. Start the conversation.

Write the first post